1Assistant Professor, Department of Physical Education and Sports Sciences, Faculty of Human Sciences, Qaem Shahr Branch, Islamic Azad University, Qaem Shahr, Iran
2Department of Exercise Physiology, Faculty of Human Sciences, Sari Branch, Islamic Azad University, Sari, Iran
3Associate Professor, Department of Exercise Physiology, Faculty of Human Sciences, Sari Branch, Islamic Azad University, Sari, Iran
Background & Aims: Numerous studies have reported the renoprotective effects of exercise in both human and animal models of diabetic nephropathy. However, detailed mechanism of action by which exercise has a favorable influence on renal fibrogenic factors is not yet fully understood. Therefore, the aim of this study was to assess the effect of swimming exercise on the activity of renal matrix mettaloproteinase-2 (MMP-2) and transforming growth factor-β1 (TGF- β1) in rats with diabetes.
Methods: The study sample consisted of 28 male Wistar rats that were randomly divided into 4 groups (7 rats per group) of control, diabetes, exercise, and diabetes-exercise. Diabetes was induced through an intraperitoneal injection of alloxan (90 mg/kg) in rats. The animals received swimming exercise for 6-30 minutes per day, 5 days a week for 8 weeks. The rats were sacrificed 72 hours after the last treatments and renal MMP-2 activity and TGF- β1 level were evaluated by Zymography and ELIZA (enzyme-linked immunosorbent assay) method. Data were analyzed using one-way analysis of variance.
Results: Diabetes induction significantly increased renal TGF-β1 (P < 0.001) and decreased MMP-2 activity (P < 0.001) compared with the control group. Furthermore, 8 weeks of swimming exercise was associated with a significant decrease in renal TGF-β1 level (P = 0.001) and elevated MMP-2 activity (P = 0.001) in rats in the diabetes-exercise group.
Conclusion: It seems that the renoprotective effects of regular swimming exercise against diabetes-induced kidney damage may be partly mediated via the up-regulation of renal MMP-2 activity and reduction of TGF-β1 level in diabetic renal tissue.
Wang X, Yan L, Chen W, Xu L, Zhang X. The renal protective effects of cilostazol on suppressing pathogenic thrombospondin-1 and transforming growth factor-beta expression in streptozotocin-induced diabetic rats. J Int Med Res 2009; 37(1): 145-53.
Ma LJ, Fogo AB. Modulation of glomerulosclerosis. Seminars in Immunopathology 2007; 29(4): 385-95.
Mason RM, Wahab NA. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 2003; 14(5): 1358-73.
McLennan SV, Kelly DJ, Cox AJ, Cao Z, Lyons JG, Yue DK, et al. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia 2002; 45(2): 268-75.
Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, et al. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy. Nephrol Dial Transplant 2006; 21(9): 2406-16.
Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats. Chin Med J(Engl) 2006; 119(10): 814-21.
Chung AW, Hsiang YN, Matzke LA, McManus BM, van Breemen C, Okon EB. Reduced expression of vascular endothelial growth factor paralleled with the increased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in human type 2 diabetic arterial vasculature. Circ Res 2006; 99(2): 140-8.
Lewandowski K, Banach E, Bienkiewicz M, Lewinski A. Matrix metalloproteinases in type 2 diabetes and non-diabetic controls: effects of short-term and chronic hyperglycaemia. Arch Med Sci 2011; 7(2): 294-303.
Lee HS. Pathogenic role of TGF- ß in diabetic nephropathy. J Diabetes Metab 2013; S9: 1-7.
Ban CR, Twigg SM. Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. Vasc Health Risk Manag 2008; 4(3): 575-96.
Lane PH, Sun J, Devish K, Langer WJ. Dissociation of renal TGF-beta and hypertrophy in female rats with diabetes mellitus. Am J Physiol Renal Physiol 2004; 287(5): F1011-F1020.
Xu J, Lee ES, Baek SH, Ahn SY, Kim S, Na KY, et al. Effect of bilirubin on triglyceride synthesis in streptozotocin-induced diabetic nephropathy. J Korean Med Sci 2014; 29(Suppl 2): S155-S163.
Kurdak H, Sandikci S, Ergen N, Dogan A, Kurdak SS. The effects of regular aerobic exercise on renal functions in streptozotocin induced diabetic rats. J Sports Sci Med 2010; 9(2): 294-9.
Boor P, Celec P, Behuliak M, Grancic P, Kebis A, Kukan M, et al. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats. Metabolism 2009; 58(11): 1669-77.
Peng C, Chen KC, Hsieh C, Peng RY. Swimming exercise prevents fibrogenesis in chronic kidney disease by inhibiting the myofibroblast transdifferentiation. PLoS One 2012; 7(6): e37388.
Santos Silva KA, de Alcântara Santos R, Arlotti MR, Jorge L, da Silva Luiz R, Rampaso RR, et al. Progressive resistance exercise training attenuated renal damages, but did not improve Muscle Force in STZ-Induced Diabetic Rats. J Diabetes Metab 2014; 5: 461.
Tzeng TF, Liou S, Chang C, Liu M. Zerumbone, a tropical ginger sesquiterpene, ameliorates streptozotocin-induced diabetic nephropathy in rats by reducing the hyperglycemia-induced inflammatory response. Nutr Metab (Lond) 2013; 10: 64.
Wenbin Z, Guojun G. Resveratrol ameliorates diabetes-induced renal damage through Regulating the expression of TGF-beta1, collagen IV and Th17/Treg-related cytokines in rats. West Indian Med J 2014; 63(1): 20-5.
Habibian M, Farzanegi P, Azimi GH. Therapeutic effect of swimming training and arbutin supplement on diabetes-induced renal oxidative stress. Daneshvar Med 2014; 22(114): 13-20. [In Persian].
Palladini G, Ferrigno A, Rizzo V, Tarantola E, Bertone V, Freitas I, et al. Lung matrix metalloproteinase activation following partial hepatic ischemia/reperfusion injury in rats. The Scientific World Journal 2014; 2014: 10.
Karamessinis PM, Tzinia AK, Kitsiou PV, Stetler-Stevenson WG, Michael AF, Fan WW, et al. Proximal tubular epithelial cell integrins respond to high glucose by altered cell-matrix interactions and differentially regulate matrixin expression. Lab Invest 2002; 82(8): 1081-93.
Sharma K, Jin Y, Guo J, Ziyadeh FN. Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 1996; 45(4): 522-30.
Hayashi K, Sasamura H, Ishiguro K, Sakamaki Y, Azegami T, Itoh H. Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2. Kidney Int 2010; 78(1): 69-78.
Lenz O, Elliot SJ, Stetler-Stevenson WG. Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 2000; 11(3): 574-81.
Ishikawa Y, Gohda T, Tanimoto M, Omote K, Furukawa M, Yamaguchi S, et al. Effect of exercise on kidney function, oxidative stress, and inflammation in type 2 diabetic KK-Ay mice. Experimental Diabetes Research 2012; 2012: 10.
Cunha TS, Ronchi F, Sakata MM, Arita DY, Colucci JA, Perez JD, et al. Exercise training reduces kidney angiotensin ii levels and attenuates renal dysfunction in animal diabetic nephropathy [Online]. [cited 2010]; Available from: URL: http://professional.diabetes.org/Abstracts_Display.aspx?TYP=1&CID=79058